翻訳と辞書 |
Lucinactant
Lucinactant (trade name Surfaxin) is a liquid medication used to treat infant respiratory distress syndrome.〔()〕 It was approved for use in the United States by the U.S. Food and Drug Administration (FDA) on March 6, 2012. ==Medical uses== Lucinactant is indicated to improve lung function and reduce duration and risk of mechanical ventilation in children. It can be used up to two years of age and is specified for children who are diagnosed with acute respiratory failure following exposure to a pathogen such as RSV or influenza, including H1N1.〔 〕 Lucinactant is also used to treat meconium aspiration syndrome.〔
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Lucinactant」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|